You are now leaving GSK’s website

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.

Continue

Go back

What is Bexsero?

  • Bexsero is a Meningococcal group B Vaccine. 
  • It contains four different components from the surface of the bacteria Neisseria meningitidis group B. 
  • It is given to individuals from 2 months of age and older to help protect against disease caused by the Neisseria meningitidis group B bacteria. These bacteria can cause serious, and sometimes life-threatening, infections such as meningitis (inflammation of the covering of the brain and spinal cord) and sepsis (blood poisoning).

How does it work?

  • The vaccine works by specifically stimulating the body’s natural defense system of the vaccinated person. This results in protection against the disease. 
  • Talk to your doctor, nurse or pharmacist before you or your child receive Bexsero.

Safety

  • A full list of side effects can be found in the patient information leaflet.
  • Do not use Bexsero if you or your child are allergic to the active substances or any of the other ingredients of this vaccine.
  • Very common side effects (these may affect more than 1 in 10 people) for infants and children (up to 10 years of age) include fever (≥38ºC), loss of appetite, tenderness or discomfort at the injection site (including severe injection site tenderness resulting in crying when injected limb is moved), painful joints, skin rash (children aged 12 months to 23 months) (uncommon after booster), sleepiness, feeling irritable, unusual crying, vomiting (uncommon after booster), diarrhea and headache. Very common side effects (these may affect more than 1 in 10 people) for adolescents (from 11 years of age) and adults include pain at the injection site resulting in inability to perform normal daily activity, painful muscles and joints, nausea, generally feeling unwell and headache.
  • A common side effect (this may affect less than 1 in 10 people to more than 1 in 100 people) for infants and children (2 to 10 years of age) is a skin rash.

View summary of product characteristics (GB)
View patient information leaflet (GB)

View summary of product characteristics (NI)
View patient information leaflet (NI)

 

If you experience any side effects, talk to your doctor, pharmacist or nurse. This includes any side effects not listed in the package leaflet.
You can also report side effects directly via the Yellow Card Scheme at https://yellowcard.mhra.gov.uk.
By reporting side effects you can help provide more information on the safety of this medicine.

Bexsero is a registered trademark of the GlaxoSmithKline group of companies.